DRDATSONS

Dr. Datson's Labs Limited has informed the Exchange that in the Meeting of the Board of Directors of the Company held on February 14, 2015 it was decided: (1) To appoint Mr. Mahesh Vaidya, as the Vice Chairman and Managing Director of the company w.e.f. February 14, 2015. (2) To accept the resignation of Dr. Kannan Vishwanath, as the Vice Chairman and Managing Director of the company w.e.f. February 14, 2015

Dr. Datson's Labs Limited has informed the Exchange regarding outcome of the Board Meeting of the Company held on January 05, 2015.

Dr. Datson's Labs Limited has informed the Exchange regarding a Outcome of Board Meeting of the Company held on December 15, 2014.

Dr. Datson's Labs Limited has informed the Exchange regarding Outcome of Board Meeting held on November 11, 2014.

Dr. Datson's Labs Limited has informed the Exchange that the Board of Directors of the Company held on August 14, 2014, decided: 1) Adopted and Approved the Notice & Directors Report along with the Corporate Governance Report of the Company for the financial year 2013-14; 2) Authorize Dr. Kannan Vishwanath, Vice Chairman & Managing Director and/or Mr. Yogesh Patel, Company Secretary of the Company, to oversee the entire E-voting Process at the AGM of the Company; 3) Appointed Mr. Deep Shukla, Practicing Company Secretary as a Scrutinizer to conduct the entire voting Process at the A

Dr. Datson's Labs Limited has informed the Exchange that the Board of Directors of the Company in its meeting held on July 5, 2014 has : Approved and finalized the Notice of Postal Ballot under Section 110 of the Companies Act, 2013 for the following matter: 1) To Increase Authorized Capital of the Company from Rs. 80,00,00,000/-( Rupees Eighty Crore Only) divided in to 8,00,00,000(Eight Crores Only) equity shares of Rs.10/-( Rupees Ten only) to Rs. 110,00,00,000/-( Rupees One Hundred Ten Crores Only) divided in to 11,00,00,000(Eleven Crores Only) equity shares of Rs.10/-( Rupees Ten only) and

Dr. Datson's Labs Limited has informed the Exchange regarding a Outcome of Board Meeting of the Company held on June 27, 2014.

Dr. Datson's Labs Limited has informed the Exchange regarding the outcome of board meeting of the Company held on June 02, 2014.

Dr. Datson's Labs Limited has informed the Exchange regarding a outcome of Board Meeting held on May 15, 2014.

Dr. Datson's Labs Limited has submitted to the Exchange the outcome of Meeting of the Board of Directors of the Company held on May 10, 2014.

Dr. Datson's Labs Limited has informed the Exchange regarding the Outcome of the meeting of the Board of Directors of the Company held on March 18, 2014.

Dr. Datson's Labs Limited has informed the Exchange that due to non-availability of requisite quorum the scheduled Meeting of the Board of Directors of the Company to be held on March 15, 2014, could not be held and it is decided to the said board meeting to be held the day and date of which will be to the exchange separately.

Aanjaneya Lifecare Limited has informed the Exchange that the Board of Directors of the Company at its meeting held on August 30, 2013 :(1)To Issue 25,00,000 optionally convertible warrants on preferential basis to Promoter at a price as determined under the SEBI (ICDR) Regulations, 2009, as amended, subject to the approval members of the company.

Aanjaneya Lifecare Limited has informed the Exchange regarding outcome of the Board of Directors Meeting of the Company held on June 24, 2013.

Aanjaneya Lifecare Limited has informed the Exchange that the Board of Directors of the Company at its meeting held on May 30, 2013 decided to nominate Mr. Chandulal Champaklal Shah, as Chairman Emeritus. Mr. Chandulal Shah is an eminent social worker and was awarded Dalit Mitra Puraskar and he is also Special Executive Officer of Government of Maharashtra. He has over 35 years experience in business. He will not be a board member of the company.

Aanjaneya Lifecare Limited has informed the Exchange that the Board of Directors of the Company at its meeting held on March 18, 2013 have decided that the date of opening of issuance of FCCB up to USD 75 million is on March 18, 2013.

Aanjaneya Lifecare Limited has informed the Exchange that the Board of Directors of the Company at its meeting held on March 05, 2013 inter alia, have decided that the date of opening of issuance of FCCB up to USD 75 million is on March 12, 2013.

Aanjaneya Lifecare Limited has informed the Exchange regarding the Outcome of the Meeting of the Board of Directors of the Company held on October 16, 2012.

Aanjaneya Lifecare Limited has informed the Exchange that the Board of Directors of the Company at its meeting held on August 13, 2012 has decided to finalise the modalities to open branch offices outside India i.e. in Uganda, Tanzania, Dubai and Singapore.

Aanjaneya Lifecare Limited has informed the Exchange that the Board of Directors of the Company at its meeting held on April 13, 2012 : (1) Approved and accepted the retirement of Mr. Kashi Vishwanathan, Chairman and Whole time Director of the Company as per the terms of reference of the code of conduct drafted for the Management & Board of Directors of the Company.

Aanjaneya Lifecare Limited has informed the Exchange that in the Meeting of the Board of Directors of the Company held on April 02, 2012, the Board of Directors decided : (1) To issue securities/Foreign Currency Convertible Bonds to the tune of 75 million USD to Qualified Institutional Buyers (QIBs) [to be identified by the Investment Committee of the Company] through Qualified Institutional Placement (QIP) in tranches over a period of 18 months out of which first tranche would aggregate to 25 million USD to be allocated for ongoing capital expenditure & potential acquisitions; (2) To appoint

Aanjaneya Lifecare Limited has informed the Exchange that Meeting of the Board of Directors of the company held on March 28, 2012, the Board has (1) Approved and allotted 13,10,484 Equity Shares of Rs 10/- each on preferential basis at price of Rs. 496/- per equity share for consideration other than cash to M/s Apex Drugs and Intermediates Limited (being Non Promoter) on Preferential allotment basis in accordance with the resolution passed by the members at the Extra General Meeting held on February 27, 2012.

Aanjaneya Lifecare Limited has informed the Exchange regarding the Outcome of the Meeting of the Board of Directors of the Company held on February 02, 2012.

Aanjaneya Lifecare Limited has informed the Exchange that the Board of Directors of the Company at its meeting held on January 9, 2012 has: (1) Decided to authorize Dr. Kannan Vishwanath, Managing Director of the Company, to negotiate the terms and conditions for acquisition of 100% Assets and business of Apex Drugs & Intermediates Limited; (2) Decided to open subsidiary companies and offices in Singapore and U.A.E and authorize Dr. Kannan Vishwanath, Managing Director or any of the Director of the Company.

Aanjaneya Lifecare Limited has informed the Exchange that the Board of Directors of the Company at its meeting held on July 15, 2011, has : (1) Ratified the resignation tendered by Mr. Kalidas Patel as the Director of the Company and appointed Mr. Paul Chakkapan Naythatil as an Additional Independent Non Executive Director of the Company; (2) Ratified the reconstitution of the Audit Committee of the Company consequent to change in the composition of the Board of Directors as mentioned above.

Aanjaneya Lifecare Limited has informed the Exchange that the Board of Directors of the Company at its meeting held on June 27, 2011 decided following: Proposed that an application be made to the Register of Companies, Maharashtra, at Mumbai for obtaining extension for holding the Annual General Meeting of the Company for the financial year ended 2010-11 on or before November 03, 2011 (as the previous AGM was held on May 04, 2011).